Jeanny B. Aragon-Ching, MD, FACP, explains reliable molecular markers that can help identify high-risk muscle-invasive bladder cancer patients who should receive neoadjuvant therapy.
Molecular markers in high-risk muscle-invasive bladder cancer
Jeanny B. Aragon-Ching, MD, FACP, explains reliable molecular markers that can help identify high-risk muscle-invasive bladder cancer patients who should receive neoadjuvant therapy.